Clinical Trials Directory

Trials / Unknown

UnknownNCT02721628

Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus

Femtosecond Laser Assisted Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus

Detailed description

Keratoconus is a bilateral corneal ecstatic disease which is not uncommon and always behaves progressively and results in visual impairment by inducing irregular astigmatism and corneal opacities. Collagen Cross-Linking (CXL) is widely used in progressive keratoconus. The cornea is soaked with a riboflavin solution and then being exposed to ultraviolet-A radiation. The performance creates links between collagen fibrils in order to rigidify the corneal stroma and slow down the progression of keratoconus. However, the effectiveness is not satisfied and accompanied with risks of side effects and serious complications, such as pain for the first two post-operative days, temporary loss of visual acuity during the first three months, infection and stromal opacity due to corneal scarring. Epi-keratoplasty is a reversible technique in which a corneal graft is transplanted on the recipients' eye with only removal of the epithelium of the receptor cornea. The procedure was assisted by femtosecond laser which allows precisely and neatly cutting. The graft strengths the whole host corneal rigidity and roughness and therefore renders the progression of keratoconus.

Conditions

Interventions

TypeNameDescription
PROCEDUREEpi-keratoplastyFemtosecond laser assisted Epi-keratoplasty
PROCEDURECollagen Cross-LinkingCollagen Cross-Linking: Standard procedure, which is descriptor bellows: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
DEVICEFemtosecond laserUse in the epic-keratoplasty surgery

Timeline

Start date
2015-09-01
Primary completion
2017-12-01
Completion
2018-03-01
First posted
2016-03-29
Last updated
2016-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02721628. Inclusion in this directory is not an endorsement.